These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
882 related articles for article (PubMed ID: 25763798)
1. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats. Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798 [TBL] [Abstract][Full Text] [Related]
2. Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy. Mondello S; Shear DA; Bramlett HM; Dixon CE; Schmid KE; Dietrich WD; Wang KK; Hayes RL; Glushakova O; Catania M; Richieri SP; Povlishock JT; Tortella FC; Kochanek PM J Neurotrauma; 2016 Mar; 33(6):595-605. PubMed ID: 26671651 [TBL] [Abstract][Full Text] [Related]
3. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury. Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543 [TBL] [Abstract][Full Text] [Related]
4. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960 [TBL] [Abstract][Full Text] [Related]
5. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings. Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330 [TBL] [Abstract][Full Text] [Related]
6. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children. Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142 [TBL] [Abstract][Full Text] [Related]
7. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT; J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516 [TBL] [Abstract][Full Text] [Related]
8. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury. Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005 [TBL] [Abstract][Full Text] [Related]
9. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury. Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. Dixon CE; Bramlett HM; Dietrich WD; Shear DA; Yan HQ; Deng-Bryant Y; Mondello S; Wang KK; Hayes RL; Empey PE; Povlishock JT; Tortella FC; Kochanek PM J Neurotrauma; 2016 Mar; 33(6):553-66. PubMed ID: 26671075 [TBL] [Abstract][Full Text] [Related]
11. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury. Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555 [TBL] [Abstract][Full Text] [Related]
12. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects. Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT; Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263 [TBL] [Abstract][Full Text] [Related]
14. Early loss of astrocytes after experimental traumatic brain injury. Zhao X; Ahram A; Berman RF; Muizelaar JP; Lyeth BG Glia; 2003 Nov; 44(2):140-52. PubMed ID: 14515330 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Liu MC; Akinyi L; Scharf D; Mo J; Larner SF; Muller U; Oli MW; Zheng W; Kobeissy F; Papa L; Lu XC; Dave JR; Tortella FC; Hayes RL; Wang KK Eur J Neurosci; 2010 Feb; 31(4):722-32. PubMed ID: 20384815 [TBL] [Abstract][Full Text] [Related]
16. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury. Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. Bramlett HM; Dietrich WD; Dixon CE; Shear DA; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM J Neurotrauma; 2016 Mar; 33(6):538-52. PubMed ID: 26670694 [TBL] [Abstract][Full Text] [Related]
18. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151 [TBL] [Abstract][Full Text] [Related]
19. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury. Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 Minutes of Traumatic Brain Injury. Papa L; McKinley WI; Valadka AB; Newman ZC; Nordgren RK; Pramuka PE; Barbosa CE; Brito AMP; Loss LJ; Tinoco-Garcia L; Hinson HE; Schreiber MA; Rowell SE JAMA Netw Open; 2024 Sep; 7(9):e2431115. PubMed ID: 39230905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]